The cardiovascular risk of febuxostat among patients with hyperuricemia or gout compared with allopurinol: A population-based study in Taiwan

被引：0
|
作者：
Huang, Chien-Huei [1 ]
Su, Chien-Chou [2 ,3 ]
Liu, Pheng-Ying Yeh [1 ]
Yang, Yea-Huei Kao [2 ,3 ]
Cheng, Ching-Lan [2 ,3 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
85
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study
    Lin, Hsiu-Chen
    Daimon, Masao
    Wang, Ching-Hung
    Ho, Yi
    Uang, Yow-Shieng
    Chiang, Shuo-Ju
    Wang, Li-Hsuan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 233 : 85 - 90
  • [22] Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
    Su, Ching-Yen
    Shen, Li-Jiuan
    Hsieh, Song-Chou
    Lin, Lian-Yu
    Lin, Fang-Ju
    MAYO CLINIC PROCEEDINGS, 2019, 94 (07) : 1147 - 1157
  • [23] Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
    Pawar, Ajinkya
    Desai, Rishi J.
    Liu, Jun
    Kim, Erin
    Kim, Seoyoung C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (07):
  • [24] Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
    Kang, Eun Ha
    Choi, Hyon K.
    Shin, Anna
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kim, Seoyoung C.
    RHEUMATOLOGY, 2019, 58 (12) : 2122 - 2129
  • [25] Systematic review of clinical effectiveness of allopurinol in treating gout, compared to febuxostat, among patients with confirmed diagnosis of gout
    Zurmi, I. B.
    Abdulkareem, I. H.
    Carroll, C.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 81 - 81
  • [26] RISK OF FRACTURE AMONG PATIENTS WITH GOUT: A POPULATION-BASED COHORT STUDY
    Sultan, A. Abdul
    Whittle, R.
    Muller, S.
    Roddy, E.
    Mallen, C.
    Blagojevic-Bucknall, M.
    Helliwell, T.
    Hider, S.
    Paskins, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 751 - 751
  • [27] `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea
    Hoon Jeong
    Eunmi Choi
    Ahyoung Suh
    Myungsik Yoo
    Bonggi Kim
    Rheumatology International, 2023, 43 : 265 - 281
  • [28] Cardiovascular Outcomes of Treatment with Febuxostat and Allopurinol in Gout Patients with Kidney Disease
    White, William B.
    Gunawardhana, Lhanoo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [29] Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
    Guan, Xudong
    Zhang, Shengzhao
    Liu, Jiayan
    Wu, Fengbo
    Zhou, Lingyan
    Liu, Ying
    Su, Na
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Gout, flares, and allopurinol use: a population-based study
    Charlotte Proudman
    Susan E. Lester
    David A. Gonzalez-Chica
    Tiffany K. Gill
    Nicola Dalbeth
    Catherine L. Hill
    Arthritis Research & Therapy, 21
12345